ABOS
Acumen Pharmaceuticals Inc
NASDAQ: ABOS · HEALTHCARE · BIOTECHNOLOGY
$2.34
-4.88% today
Updated 2026-04-29
Market cap
$169.01M
P/E ratio
—
P/S ratio
538.78x
EPS (TTM)
$-2.00
Dividend yield
—
52W range
$1 – $4
Volume
0.6M
Acumen Pharmaceuticals Inc (ABOS) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | $7.32M | $44.43M | $230.33M | $196.59M | $310.13M | $238.99M |
| Cash & equivalents | $6.55M | $43.78M | $122.16M | $130.10M | $66.89M | $35.63M |
| Current assets | $7.18M | $44.43M | $198.66M | $180.33M | $246.62M | $178.31M |
| Total liabilities | $18.74M | $63.02M | $5.15M | $7.81M | $43.15M | $57.18M |
| Current liabilities | $1.34M | $6.37M | $5.15M | $7.81M | $12.97M | $27.61M |
| Long-term debt | — | — | — | — | $27.34M | $28.45M |
| Shareholder equity | $-11.42M | $-18.59M | $225.18M | $188.78M | $266.97M | $181.82M |
| Retained earnings | $-19.64M | $-26.96M | $-127.57M | $-170.43M | $-222.80M | $-325.13M |
| Accounts receivable | $30000.00 | $109000.00 | $-83.00 | $-199.00 | $225000.00 | $398000.00 |
| Inventory | $49000.00 | $91000.00 | $83.00 | $199000.00 | $98000.00 | $159000.00 |
| Goodwill | — | — | — | — | — | — |